Vitamin D status and Its association with haematological inflammatory indices and cardiometabolic risk profiles: a retrospective cross-sectional study - Takeaways - MDSpire

Vitamin D status and Its association with haematological inflammatory indices and cardiometabolic risk profiles: a retrospective cross-sectional study

  • By

  • Yaqeen Mohammed Al-Essa

  • Hussain Khalifa Aljumah

  • Zainab Younis Al saeed

  • Raneem Abdullah AlQattan

  • Danah Yousef Alquwayzani

  • Ghadeer kazem Al-Yousef

  • Ayah Salem AL owdah

  • Mujtaba Abbas Alzuwayr

  • Eman Elsheikh

  • June 10, 2026

  • 0 min

Share

  • 1

    Vitamin D deficiency is linked to adverse inflammatory and cardiometabolic profiles in adults.

  • 2

    The study analyzed 1,100 adults to evaluate the relationship between vitamin D levels and inflammatory indices.

  • 3

    Haematological inflammatory indices include NLR, PLR, MLR, and SII, which are associated with systemic inflammation.

  • 4

    Vitamin D status may influence the relationship between haematological inflammatory indices and cardiometabolic risk markers.

  • 5

    Findings suggest that low vitamin D status coexists with less favorable inflammatory and metabolic profiles.

Original Source(s)

Vitamin D status and Its association with haematological inflammatory indices and cardiometabolic risk profiles: a retrospective cross-sectional study

  • by Yaqeen Mohammed Al-Essa, Hussain Khalifa Aljumah, Zainab Younis Al saeed, Raneem Abdullah AlQattan, Danah Yousef Alquwayzani, Ghadeer kazem Al-Yousef, Ayah Salem AL owdah, Mujtaba Abbas Alzuwayr, Eman Elsheikh

  • June 10, 2026

Related Content

Mass Spec Roundup: Ubiquitin, Pollutants, and Pain

Non-protein ubiquitination, cryogenic chemical mapping, wastewater antidepressants, and new molecular clues to post-stroke pain

  • June 10, 2026

  • 6 min
Impact of whole-body vibration on anthropometric measurements and body composition in overweight and obese university students: a randomized controlled trial

Molecular Interplay between hypertension and dyslipidemia in cardiovascular pathogenesis: toward precision-based therapeutic strategies